All told, nursing homes that received a clean bill of health earlier this year saw about 290,000 coronavirus cases and 43,000 deaths among residents and staff, state and federal data shows. More
The idea behind the new regulations on insurers is to empower patients to become better consumers of health care, thereby helping to drive down costs. More
"We are disappointed that DOJ forfeited yet another opportunity to hold members of the Sackler family fully accountable," the lawmakers said. More
As many employers move to bring staff back, a growing number of workers are concerned about unsafe conditions. More
The FDA rappling with fundamental questions about algorithmic bias, data transparency, and access to AI tools in medicine. More
Despite larger health threats consuming the nation this year, pharma did not let up on their fear-mongering advertisements. Check out a few of the scariest-- if you dare! More
Gilead said it spent $1 billion to develop remdesivir. The NIH invested as much as $6.5 billion in it between 2000 and 2019. More
The complex business structures of some private equity-backed dermatology groups allowed them to receive millions in COVID-19 funds. More
The University of Virginia promised reforms but has stopped short of announcing them, while hospital giant VCU Health has freed tens of thousands from property liens. More
Denials expose ways hospitals put finances ahead of pandemic response as coronavirus hospitalizations continue to surge More
Northwell Health's $2.5 billion expansion plan for the hospital in Manhattan's Upper East Side, one of New York City's whitest enclaves, faces vehement opposition from healthcare advocates who say the project neglects communities of color. More
The incorrect penalties stem from margins of error associated with the 30-day risk-adjusted readmission measure the program relies on. More
Federal law eliminates consumer cost sharing for multiple methods of colorectal cancer screening, including colonoscopy when done by an in-network provider. However, some patients having screening incur considerable out-of-pocket costs because out-of-network bills are not included in federal mandates. More
At a presentation for the Massachusetts Health Data Collaborative, Vikas Saini and Shannon Brownlee discussed why they created the Lown Hospitals Index, how the metrics were developed, and what the results show about hospitals in Massachusetts. Watch the full presentation here! More
The Trump Administration is poised to make a settlement with Purdue Pharma that it can claim as a victory for opioid victims. But the proposed outcome would leave the company’s owners enormously wealthy—and off the hook for good. More
The president said at Tuesday’s debate that he lowered insulin prices. That’s not true — and, for some, the drug’s expense is a fatal barrier. More
Amid the COVID-19 pandemic, hospice's new H Word is Hero! Stripped of the illusion of security, the public sees the immediate and enduring value of palliative care, home health care, nursing home care, and hospice. More
Enormous drug company profits are the primary driver of soaring prescription drug prices in America, according to a damning investigation that Democrats on the House Oversight Committee began releasing Wednesday. More
The UMass Memorial HealthAlliance-Clinton Hospital campus in Leominster leads the state in the new Lown Institute Hospitals Index, a ranking of 3,300 hospitals and 300 hospital systems launched this summer. “It’s not necessarily the usual suspects that you’re going to find at the top of these rankings,” said Shannon Brownlee, the institute’s senior vice president. Lown Institute President Dr. Vikas Saini said the index is meant to help shape a discussion around health-care quality and unearth new ideas, rather than serve as a shopping guide for consumers. More
“Our study shows that there are evidence gaps that the FDA needs to address in approving new opioids,” said study co-author Thomas Moore. More